Status:
UNKNOWN
Weight Loss Interventions for Obesity
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Overweight
Weight Loss
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
Numerous barriers towards weight management among Singaporeans with obesity exists, which involves environmental and self-regulation factors (i.e. motivation and hunger). Hence, the provision of healt...
Detailed Description
In Singapore, the widespread availability of local meals and concerns of overconsumption due to a lack of internal self-regulation skills for hunger predisposes an increased energy intake. Furthermore...
Eligibility Criteria
Inclusion
- Aged 21 to 75 years old
- Body Mass Index \>= 27.5kg/m2
- Own a smartphone
- Literacy in English
- NUH staff
Exclusion
- Intention of pregnancy; Pregnancy; Lactating individuals
- Type 1 Diabetes Mellitus or Type 2 Diabetes Mellitus on insulin treatment
- Untreated Endocrinopathy (e.g., hyper/hypothyroidism)
- Advanced kidney disease
- Abnormal liver function test assessed at screening
- Heart diseases
- Severe cognitive or psychiatric disabilities/disorders (e.g., eating disorders, depression)
- Active malignancies
- Taking medications that affect appetite or induce weight loss; previous or plans for bariatric surgery.
Key Trial Info
Start Date :
July 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06022796
Start Date
July 21 2023
End Date
May 1 2024
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, 119074